Dr. Greesh John, M.D Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 598 Cynwood Dr Ste 105, Easton, MD 21601 Phone: 855-527-7246 Fax: 866-229-5063 |
News Archive
In just under a month the world's attention will be focused on Vancouver and the 2010 Olympic Winter Games. The world's best athletes will be competing in a wide variety of challenging and high pressure events that will put incredible demands on their bodies. The possibility of getting injured is a reality every Olympic athlete has to contend with.
While endogenous estrogen (i.e., estrogen produced by ovaries and by other tissues) does have a well-known carcinogenic impact, hormone replacement therapy (HRT) utilizing estrogen alone (the exogenous estrogen) provides a protective effect in reducing breast cancer risk, according to study results presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
It's common sense: It is generally better to help the disabled or elderly stay in their homes and communities than to put them in institutionalized care. At home, they have a higher quality of life and a social support system.
Lombard Medical, Inc., a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today presented efficacy and safety data from the two-year follow up of the U.S. PYTHAGORAS pre-marketing approval (PMA) trial of Aorfix, the first and only endovascular stent graft with global approvals for the treatment of patients with aortic neck angulations up to 90 degrees.
Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc. (NASDAQ:IPXL), today announced that it has initiated a multinational Phase III trial of its late-stage drug candidate IPX066 in advanced Parkinson's disease (PD) patients.
› Verified 8 days ago